ADC Therapeutics Cash Flow Statement (2020-2026) | ADCT

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-72.57M-71.55M-35.52M-16.66M-64.37M-50.61M-18.15M-59.43M-48.20M-45.30M-46.00M-35.95M-43.71M-38.60M-56.65M-40.97M-32.97M
Depreciation and Depletion (Quarter)
0.26M0.27M0.32M0.34M0.33M0.33M0.34M0.34M0.34M0.36M
Share-based Compensation (Quarter)
18.27M14.80M13.46M13.40M13.82M14.56M7.54M8.07M1.12M2.08M2.22M0.16M1.99M2.81M1.62M2.42M1.81M2.00M0.67M2.44M
Deferred Taxes (Quarter)
-0.07M-5.10M-0.58M42.85M
Gains from Investment Securities (Quarter)
-0.62M-0.02M-0.14M0.28M3.07M2.23M-1.13M-0.00M-2.23M
Asset Writedowns and Impairment (Quarter)
1.94M-0.54M0.05M0.73M0.83M0.75M0.29M0.48M1.25M0.39M0.24M0.41M1.47M
Cash from Operations (Quarter)
-58.01M-58.59M-61.63M-33.88M-53.01M2.19M-53.61M-15.39M-34.99M-36.67M-31.63M-44.09M-32.84M-25.04M-21.85M-56.33M-24.09M-29.63M-31.12M-29.71M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.04M0.03M0.03M0.03M0.03M0.03M0.03M0.05M0.05M0.05M
Amortization of Deferred Charges (Quarter)
0.46M0.54M0.57M0.51M0.51M0.44M0.52M0.45M0.46M0.65M0.73M0.25M0.23M
Depreciation & Amortization (CF) (Quarter)
0.26M0.27M0.32M0.34M0.33M0.33M0.34M0.34M0.34M0.36M
Change in Working Capital
Change in Receivables (Quarter)
-2.08M-13.82M-14.32M3.47M5.89M-2.42M35.82M-48.90M-0.19M-2.70M4.00M-2.00M-0.32M1.26M-3.71M11.45M-5.58M-3.27M6.19M1.93M
Change in Inventory (Quarter)
0.35M2.05M3.48M-0.17M0.57M-0.52M0.88M2.80M0.31M0.71M0.52M0.85M-0.02M
Change in Account Payables (Quarter)
3.07M-3.93M1.74M4.38M-3.41M-1.38M0.72M-3.66M2.98M-2.71M6.57M-1.25M-4.84M4.87M3.68M-2.46M-6.22M-1.29M0.93M-3.87M
Change in Accured Expenses (Quarter)
-12.30M-3.29M-0.52M1.96M-3.54M-2.19M5.57M11.30M-20.63M12.04M-0.80M1.97M-3.18M
Change in Taxes (Quarter)
0.06M
Other Working Capital Changes (Quarter)
-0.97M0.01M-5.40M-0.35M-3.93M-1.86M17.61M-0.64M-4.29M-1.31M-1.04M0.42M0.44M1.20M-0.57M-3.86M-3.19M1.60M0.21M-2.01M
Investing Activities
Capital Expenditures (Quarter)
0.95M1.41M0.42M0.23M0.05M0.19M0.21M1.02M1.21M0.66M0.33M0.53M0.03M0.22M0.09M0.26M0.03M
Cash from Investing Activities (Quarter)
-2.85M-2.34M-0.83M-1.45M-0.69M-0.25M1.70M-1.02M-1.21M-0.66M-0.33M-0.53M-0.03M-0.22M-0.09M-0.26M0.66M-0.03M
Financing Activities
Other financing activities (Quarter)
0.42M0.35M-0.00M0.32M36.60M0.27M50.49M14.61M0.20M
Cash from Financing Activities (Quarter)
49.60M219.30M-1.22M-0.26M-0.25M2.37M-2.75M0.42M73.10M0.35M-0.00M0.36M98.70M-0.88M-1.12M0.27M93.78M-0.20M57.09M-0.58M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
-1.23M43.24M43.52M-0.02M
Additional items
Exchange Rate Effect (Quarter)
0.01M-0.07M0.03M-0.08M-0.14M-0.22M0.24M0.09M0.06M-0.12M0.15M-0.04M0.01M0.29M-0.34M0.16M0.16M0.01M-0.03M-0.01M
Change in Cash (Quarter)
-11.25M158.38M-63.68M-35.59M-53.95M4.31M-54.66M-15.98M36.90M-36.98M-31.96M-44.27M65.82M-26.14M-23.06M-56.33M69.70M-29.83M26.62M-30.32M
Free Cash Flow (Quarter)
-58.96M-59.99M-62.05M-34.11M-53.06M2.00M-53.83M-16.41M-36.20M-37.33M-31.96M-44.63M-32.88M-25.26M-21.94M-56.60M-24.09M-29.63M-31.12M-29.74M
Net Cash Flow (Quarter)
-11.25M158.38M-63.68M-35.59M-53.95M4.31M-54.66M-15.98M36.90M-36.98M-31.96M-44.27M65.82M-26.14M-23.06M-56.33M69.70M-29.83M26.62M-30.32M